These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 309344)

  • 41. The analog inhibitor, alpha-methyl dopa, as a screening agent for mutants elevating levels of dopa decarboxylase activity in Drosophila melanogaster.
    Sherald AF; Wright TR
    Mol Gen Genet; 1974; 133(1):25-36. PubMed ID: 4214992
    [No Abstract]   [Full Text] [Related]  

  • 42. Pyridoxal 5'-phosphate levels in brain after treatments which impair cerebral glucose metabolism.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Dec; 4(6):821-6. PubMed ID: 44547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylase.
    Inagaki C; Tanaka C
    Biochem Pharmacol; 1978 Apr; 27(7):1081-6. PubMed ID: 26357
    [No Abstract]   [Full Text] [Related]  

  • 44. The selection for mutants in Drosophila melanogaster hypersensitive to alpha-methyl dopa, a dopa decarboxylase inhibitor.
    Sparrow JC; Wright TR
    Mol Gen Genet; 1974 May; 130(2):127-41. PubMed ID: 4209419
    [No Abstract]   [Full Text] [Related]  

  • 45. Dopamine metabolism following irreversible inactivation of aromatic amino acid decarboxylase in retina.
    Parkinson D; Baughman R; Masland RH; Rando RR
    J Neurosci; 1981 Nov; 1(11):1205-10. PubMed ID: 6796656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of aromatic L-amino acid decarboxylase in serum of various animals by high-performance liquid chromatography with electrochemical detection.
    Rahman MK; Nagatsu T; Kato T
    Life Sci; 1981 Feb; 28(5):485-92. PubMed ID: 6970873
    [No Abstract]   [Full Text] [Related]  

  • 47. Inactivation of 3-(3,4-dihydroxyphenyl)alanine decarboxylase by 2-(fluoromethyl)-3-(3,4-dihydroxyphenyl)alanine.
    Maycock AL; Aster SD; Patchett AA
    Biochemistry; 1980 Feb; 19(4):709-18. PubMed ID: 7356954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of isoflavones inhibiting DOPA decarboxylase from fungi and streptomyces.
    Umezawa H; Tobe H; Shibamoto N; Nakamura F; Nakamura K
    J Antibiot (Tokyo); 1975 Dec; 28(12):947-52. PubMed ID: 1206008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endotoxin-induced suppression of rabbit kidney DOPA decarboxylase activity.
    Fritz H; Håkanson R
    Acta Physiol Scand; 1971 Jul; 82(3):300-9. PubMed ID: 4108401
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of pig kidney dopa decarboxylase by coenzyme-5-hydroxytryptophan adducts.
    Dominici P; Curini M; Minelli A; Borri Voltattorni C
    Experientia; 1984 Aug; 40(8):834-5. PubMed ID: 6468591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of L-DOPA and L-5-HTP on the visual evoked response.
    Kadobayashi I; Mori M; Tanaka K; Toyoshima A; Kato N
    Physiol Behav; 1980 Aug; 25(2):317-20. PubMed ID: 6968076
    [No Abstract]   [Full Text] [Related]  

  • 52. The pharmacological actions of 3,4-dihydroxyphenyl-alpha-methylalanine (alpha-methyldopa), an inhibitor of 5-hydroxytryptophan decarboxylase.
    SMITH SE
    Br J Pharmacol Chemother; 1960 Jun; 15(2):319-27. PubMed ID: 13832156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transition-state analogues as inhibitors of L-dopa decarboxylase.
    Brinkworth RI; Iles MM; Iskander MN; Andrews PR
    Int J Biochem; 1988; 20(11):1273-9. PubMed ID: 3248681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biochemical and behavioral effects of some substituted catechols.
    De Ropp RS; Kastl L; Furst A
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):127-32. PubMed ID: 5350775
    [No Abstract]   [Full Text] [Related]  

  • 55. Opposite effects of L-dopa and 5-HTP on spinal sympathetic reflexes.
    Hare BD; Neumayr RJ; Franz DN
    Nature; 1972 Oct; 239(5371):336-7. PubMed ID: 12635228
    [No Abstract]   [Full Text] [Related]  

  • 56. Interaction of L-DOPA decarboxylase with substrates: a spectrophotometric study.
    Fiori A; Turano C; Borri-Voltattorni C; Minelli A; Codini M
    FEBS Lett; 1975 Jun; 54(2):122-5. PubMed ID: 1079494
    [No Abstract]   [Full Text] [Related]  

  • 57. Some immunochemical properties of pig kidney DOPA decarboxylase.
    Rosei MA; Citro G; D'Erme M; Finazzi-Agrò A
    Immunol Commun; 1984; 13(4):381-9. PubMed ID: 6434407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic toxicity of carboethoxyphthalazinohydrazine and its influence on the excretion of 5-hydroxyindoleacetic acid and the activity of 5-htp-decarboxylase in white rats.
    Chruściel M
    Br J Pharmacol Chemother; 1968 Jan; 32(1):104-12. PubMed ID: 5640168
    [No Abstract]   [Full Text] [Related]  

  • 59. Microspectrograpic analysis of formaldehyde-induced fluorescence in the quail adenohypophysis after injection of L-dopa and 5-hydroxytryptophan.
    Harrison F; Liebens M; Vakaet L; Lauweryns JM
    Histochemistry; 1980; 67(2):191-8. PubMed ID: 6967477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative and immunocytochemical studies of APUD cells in airways and gut. The effects of priming with L-dopa and 5-HTP.
    Marchevsky AM; Kleinerman J
    Lung; 1983; 161(2):67-76. PubMed ID: 6188931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.